Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients
about
Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistenceNeurocognitive effects of HIV, hepatitis C, and substance use historyPathogenesis of HIV in the central nervous systemFulminant encephalopathy with basal ganglia hyperintensities in HIV-infected drug users.Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV.Effects of hepatitis C and HIV on cognition in women: data from the Women's Interagency HIV Study.Monocyte activation in HIV/HCV coinfection correlates with cognitive impairment.HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologiesPlasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection.The impact of human immune deficiency virus and hepatitis C coinfection on white matter microstructural integrity.Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis CA coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection.Peripheral neuropathy in ART-experienced patients: prevalence and risk factorsHIV-associated sensory neuropathy: risk factors and genetics.Hepatitis C virus and the brain.Neurological complications of hepatitis C infection.Neurological Complications in Controlled HIV Infection.Cognitive impairment in HIV and HCV co-infected patients: a systematic review and meta-analysis.Improvements in brain and behavior following eradication of hepatitis C.Cognitive impairment in HIV and HCV co-infected patients: a systematic review and meta-analysis
P2860
Q26825762-34A4C4EB-C4EA-4506-8660-4DDCCBEE6987Q33652957-2F5A591A-7499-48D1-B762-D4EADEAF5AEBQ33781978-3D80695A-6E82-48D5-8AAA-2B80C648D0CBQ33831555-06DB31B8-92F2-4EC2-9AAC-9F739C0E8783Q33874791-F6E156D0-7485-4166-9C1A-B2B6E183C101Q34080255-84B161D0-0DB1-4A35-883B-D322CA2E0E25Q34329530-C8627B9A-D900-4C79-B860-8324BA61435EQ34561257-A1F07B31-D22B-4385-8CDC-87CDBA1DAA54Q35175447-211A9D15-D4F7-42B1-8471-AB4B5C55E00AQ36989440-C166AC1E-0BA7-4560-8F89-050A322F605AQ37014193-0935D16A-CDCC-4547-ADAF-8A48B90AE37CQ37617639-CF30F9B3-6922-44B6-AAE4-9E916E894ABCQ37662415-ACE1A414-F9C2-4B3B-9359-3551E3E0CA2BQ37988382-A27FD7DE-8B75-42D7-AD2E-1DC0B78CCEFCQ38002147-A9D63BC8-2867-47E3-9607-1918C06331C8Q38044680-35776A40-3220-48B3-9398-A8612EABF971Q38154239-FED74AF8-E3E7-4218-89D8-64C08D3D2C48Q38626559-9195DD88-613C-4966-84E9-8BC77FFC8411Q38676897-7B53C1C8-36D8-4011-97B9-03F0EEA0162CQ58240326-B16315AC-6C59-46C7-8495-E80890D0213C
P2860
Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Effects of active HCV replicat ...... NA virally suppressed patients
@ast
Effects of active HCV replicat ...... NA virally suppressed patients
@en
Effects of active HCV replicat ...... NA virally suppressed patients
@nl
type
label
Effects of active HCV replicat ...... NA virally suppressed patients
@ast
Effects of active HCV replicat ...... NA virally suppressed patients
@en
Effects of active HCV replicat ...... NA virally suppressed patients
@nl
prefLabel
Effects of active HCV replicat ...... NA virally suppressed patients
@ast
Effects of active HCV replicat ...... NA virally suppressed patients
@en
Effects of active HCV replicat ...... NA virally suppressed patients
@nl
P2093
P2860
P1433
P1476
Effects of active HCV replicat ...... NA virally suppressed patients
@en
P2093
D B Clifford
M Smurzynski
P2860
P304
P356
10.1212/WNL.0B013E3181AF7A10
P407
P577
2009-07-28T00:00:00Z